Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laxminarayan

Showing results (361-370 of 407) with videos related to

Pageof 41
Sort By:
Diagnostics (Basel, Switzerland)|May 23, 2020
Clinical Validation of Integrated Point-of-Care Devices for the Management of Non-Communicable DiseasesK V Giriraja, Suman Govindaraj, H P Chandrakumar, et al.
The Lancet. Infectious Diseases|February 16, 2020
The Lancet Infectious Diseases Commission on antimicrobial resistance: 6 years laterRamanan Laxminarayan, Thomas Van Boeckel, Isabel Frost, et al.
The Lancet. Infectious Diseases|December 3, 2014
Assessment of empirical antibiotic therapy optimisation in six hospitals: an observational cohort studyNikolay P Braykov, Daniel J Morgan, Marin L Schweizer, et al.
Bioorganic & Medicinal Chemistry Letters|April 6, 2005
Design, synthesis and activity of novel derivatives of oxybutynin and tolterodineKirandeep Kaur, Shelly Aeron, Miriyala Bruhaspathy, et al.
Infection Control and Hospital Epidemiology|October 13, 2015
Indications and Types of Antibiotic Agents Used in 6 Acute Care Hospitals, 2009-2010: A Pragmatic Retrospective Observational StudyTheodoros Kelesidis, Nikolay Braykov, Daniel Z Uslan, et al.
Lancet (London, England)|May 26, 2024
Burden of bacterial antimicrobial resistance in low-income and middle-income countries avertible by existing interventions: an evidence review and modelling analysisJoseph A Lewnard, Esmita Charani, Alec Gleason, et al.
Environmental Health Perspectives|July 28, 2017
The Prevalence of Extended-Spectrum Beta-Lactamase-Producing Multidrug-Resistant <i>Escherichia Coli</i> in Poultry Chickens and Variation According to Farming Practices in Punjab, IndiaCharles H Brower, Siddhartha Mandal, Shivdeep Hayer, et al.
Journal of Cardiovascular Pharmacology|February 8, 2011
Concomitant angiotensin AT1 receptor antagonism and neprilysin inhibition produces omapatrilat-like antihypertensive effects without promoting tracheal plasma extravasation in the ratLaxminarayan G Hegde, Cecile Yu, Travis Renner, et al.
International Journal of Critical Illness and Injury Science|July 16, 2014
The 2014 Academic College of Emergency Experts in India's INDO-US Joint Working Group (JWG) White Paper on "Developing Trauma Sciences and Injury Care in India"Ranabir Pal, Amit Agarwal, Sagar Galwankar, et al.
ACS Medicinal Chemistry Letters|January 19, 2019
Discovery of TD-0212, an Orally Active Dual Pharmacology AT<sub>1</sub> Antagonist and Neprilysin Inhibitor (ARNI)R Murray McKinnell, Paul Fatheree, Seok-Ki Choi, et al.
Pageof 41

Showing results (361-370 of 407) with videos related to

Sort By:
Pageof 41
Diagnostics (Basel, Switzerland)|May 23, 2020
Clinical Validation of Integrated Point-of-Care Devices for the Management of Non-Communicable DiseasesK V Giriraja, Suman Govindaraj, H P Chandrakumar, et al.
The Lancet. Infectious Diseases|February 16, 2020
The Lancet Infectious Diseases Commission on antimicrobial resistance: 6 years laterRamanan Laxminarayan, Thomas Van Boeckel, Isabel Frost, et al.
The Lancet. Infectious Diseases|December 3, 2014
Assessment of empirical antibiotic therapy optimisation in six hospitals: an observational cohort studyNikolay P Braykov, Daniel J Morgan, Marin L Schweizer, et al.
Bioorganic & Medicinal Chemistry Letters|April 6, 2005
Design, synthesis and activity of novel derivatives of oxybutynin and tolterodineKirandeep Kaur, Shelly Aeron, Miriyala Bruhaspathy, et al.
Infection Control and Hospital Epidemiology|October 13, 2015
Indications and Types of Antibiotic Agents Used in 6 Acute Care Hospitals, 2009-2010: A Pragmatic Retrospective Observational StudyTheodoros Kelesidis, Nikolay Braykov, Daniel Z Uslan, et al.
Lancet (London, England)|May 26, 2024
Burden of bacterial antimicrobial resistance in low-income and middle-income countries avertible by existing interventions: an evidence review and modelling analysisJoseph A Lewnard, Esmita Charani, Alec Gleason, et al.
Environmental Health Perspectives|July 28, 2017
The Prevalence of Extended-Spectrum Beta-Lactamase-Producing Multidrug-Resistant <i>Escherichia Coli</i> in Poultry Chickens and Variation According to Farming Practices in Punjab, IndiaCharles H Brower, Siddhartha Mandal, Shivdeep Hayer, et al.
Journal of Cardiovascular Pharmacology|February 8, 2011
Concomitant angiotensin AT1 receptor antagonism and neprilysin inhibition produces omapatrilat-like antihypertensive effects without promoting tracheal plasma extravasation in the ratLaxminarayan G Hegde, Cecile Yu, Travis Renner, et al.
International Journal of Critical Illness and Injury Science|July 16, 2014
The 2014 Academic College of Emergency Experts in India's INDO-US Joint Working Group (JWG) White Paper on "Developing Trauma Sciences and Injury Care in India"Ranabir Pal, Amit Agarwal, Sagar Galwankar, et al.
ACS Medicinal Chemistry Letters|January 19, 2019
Discovery of TD-0212, an Orally Active Dual Pharmacology AT<sub>1</sub> Antagonist and Neprilysin Inhibitor (ARNI)R Murray McKinnell, Paul Fatheree, Seok-Ki Choi, et al.
Pageof 41